PT  - JOURNAL ARTICLE
AU  - Affan Shoukat
AU  - Thomas N. Vilches
AU  - Seyed M. Moghadas
AU  - Pratha Sah
AU  - Eric C. Schneider
AU  - Jaimie Shaff
AU  - Jane Zucker
AU  - Celia Quinn
AU  - Dave A. Chokshi
AU  - Alison P. Galvani
TI  - Lives saved and hospitalizations averted by COVID-19 vaccination in New York City
AID  - 10.1101/2021.07.14.21260481
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.14.21260481
4099  - http://medrxiv.org/content/early/2021/07/18/2021.07.14.21260481.short
4100  - http://medrxiv.org/content/early/2021/07/18/2021.07.14.21260481.full
AB  - Despite the emergence of highly transmissible variants, the number of cases in NYC has fallen from over 5,500 average daily cases in January, 2020 to less than 350 average daily cases in July, 2021. The impact of vaccination in saving lives and averting hospitalizations in NYC has not been formally investigated yet. We used an age-stratified agent-based model calibrated to COVID-19 transmission and vaccination in NYC to evaluate the impact of the vaccination campaign in suppressing the COVID-19 burden. We found that the vaccination campaign has prevented over 250,000 COVID-19 cases, 44,000 hospitalizations and 8,300 deaths from COVID-19 infection since the start of vaccination through July 1, 2021. Notably, the swift vaccine rollout suppressed another wave of COVID-19 that would have led to sustained increase in cases, hospitalizations and deaths during spring triggered by highly transmissible variants. As the Delta variant sweeps across the city, the findings of this study underscore the urgent need to accelerate vaccination and close the vaccine coverage gaps across the city.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the Commonwealth Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was not required as all data is publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is publicly available